BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassotti G, Blandizzi C. Understanding and treating refractory constipation. World J Gastrointest Pharmacol Ther 2014; 5(2): 77-85 [PMID: 24868488 DOI: 10.4292/wjgpt.v5.i2.77] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 George SE, Borello-france DF. Perspective on Physical Therapist Management of Functional Constipation. Physical Therapy 2017;97:478-93. [DOI: 10.2522/ptj.20160110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Bassotti G. Relamorelin to Treat Constipation: “Pusher” or Pushover? Dig Dis Sci 2016;61:658-9. [DOI: 10.1007/s10620-015-3929-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Staller K. Refractory Constipation: What is the Clinician to Do? J Clin Gastroenterol 2018;52:490-501. [PMID: 29794543 DOI: 10.1097/MCG.0000000000001049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Bassotti G, Usai Satta P, Bellini M. Plecanatide for the treatment of chronic idiopathic constipation in adult patients. Expert Rev Clin Pharmacol 2019;12:1019-26. [PMID: 31575291 DOI: 10.1080/17512433.2019.1670057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Quigley EM, Neshatian L. Advancing treatment options for chronic idiopathic constipation. Expert Opin Pharmacother. 2016;17:501-511. [PMID: 26630260 DOI: 10.1517/14656566.2016.1127356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
6 Tillou J, Poylin V. Functional Disorders: Slow-Transit Constipation. Clin Colon Rectal Surg 2017;30:76-86. [PMID: 28144215 DOI: 10.1055/s-0036-1593436] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
7 Yin J, Liang Y, Wang D, Yan Z, Yin H, Wu D, Su Q. Naringenin induces laxative effects by upregulating the expression levels of c-Kit and SCF, as well as those of aquaporin 3 in mice with loperamide-induced constipation.Int J Mol Med. 2018;41:649-658. [PMID: 29207043 DOI: 10.3892/ijmm.2017.3301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
8 Arrari F, Jabri MA, Hammami I, Sebai H. Extraction of Pectin from Orange Peel and Study of Its Protective Effect Against Loperamide-Induced Impaired Gastrointestinal Motor Functions and Oxidative Stress in Rats. J Med Food 2022. [PMID: 35143346 DOI: 10.1089/jmf.2021.0091] [Reference Citation Analysis]
9 Lu ML, He J, Lu S. Electrical stimulation therapy for slow transit constipation in children: a systematic review. Int J Colorectal Dis. 2015;30:697-702. [PMID: 25772272 DOI: 10.1007/s00384-015-2180-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 He Q, Han C, Huang L, Yang H, Hu J, Chen H, Dou R, Ren D, Lin H. Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation. J Cell Mol Med 2020;24:9349-61. [PMID: 32628809 DOI: 10.1111/jcmm.15586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Schoeters P, De Pooter K. Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy. Case Rep Gastrointest Med 2015;2015:686120. [PMID: 26770844 DOI: 10.1155/2015/686120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Bassotti G, Gambaccini D, Bellini M. Prucalopride succinate for the treatment of constipation: an update. Expert Rev Gastroenterol Hepatol. 2016;10:291-300. [PMID: 26647167 DOI: 10.1586/17474124.2016.1129897] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
13 Bassotti G. Being constipated: A bad omen for your cardiovascular system? Atherosclerosis 2016;245:240-1. [PMID: 26684285 DOI: 10.1016/j.atherosclerosis.2015.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cappelli K, Gialletti R, Tesei B, Bassotti G, Fettucciari K, Capomaccio S, Bonfili L, Cuccioloni M, Eleuteri AM, Spaterna A, Laus F. Guanylin, Uroguanylin and Guanylate Cyclase-C Are Expressed in the Gastrointestinal Tract of Horses. Front Physiol 2019;10:1237. [PMID: 31611814 DOI: 10.3389/fphys.2019.01237] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Müller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, Emmanuel A, Laroche F, Meissner W, Morlion B. Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Med 2017;18:1837-63. [PMID: 28034973 DOI: 10.1093/pm/pnw255] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
16 Mearin F, Ciriza C, Mínguez M, Rey E, Mascort J, Peña E, Cañones P, Júdez J. Guía de práctica clínica del síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: tratamiento. (Parte 2 de 2). SEMERGEN - Medicina de Familia 2017;43:123-40. [DOI: 10.1016/j.semerg.2017.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Wang L, Wang F, Zhang X, Chen Q, Xu J, Li H, Li F, Yang M, Konsue N. Transdermal Administration of Volatile Oil from Citrus aurantium-Rhizoma Atractylodis Macrocephalae Alleviates Constipation in Rats by Altering Host Metabolome and Intestinal Microbiota Composition. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9965334] [Reference Citation Analysis]
18 Yao Z, Fu S, Ren B, Ma L, Sun D. Based on Network Pharmacology and Gut Microbiota Analysis to Investigate the Mechanism of the Laxative Effect of Pterostilbene on Loperamide-Induced Slow Transit Constipation in Mice. Front Pharmacol 2022;13:913420. [DOI: 10.3389/fphar.2022.913420] [Reference Citation Analysis]
19 Wang HL. Understanding the Pathogenesis of Slow-Transit Constipation: One Step Forward. Dig Dis Sci 2015;60:2216-8. [PMID: 26088370 DOI: 10.1007/s10620-015-3754-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
20 Bassotti G, Gambaccini D, Bellini M. Velusetrag for the treatment of chronic constipation. Expert Opinion on Investigational Drugs 2016;25:985-90. [DOI: 10.1080/13543784.2016.1195369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Battaglia E, Grassini M, Dore MP, Bassotti G. Usefulness of Bisacodyl Testing on Therapeutic Outcomes in Refractory Constipation. Dig Dis Sci 2018;63:3105-11. [DOI: 10.1007/s10620-018-4988-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
22 Serra J, Mascort-roca J, Marzo-castillejo M, Aros SD, Ferrándiz Santos J, Rey Diaz Rubio E, Mearin Manrique F. Guía de práctica clínica sobre el manejo del estreñimiento crónico en el paciente adulto. Parte 2: Diagnóstico y tratamiento. Gastroenterología y Hepatología 2017;40:303-16. [DOI: 10.1016/j.gastrohep.2016.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
23 Wang YB, Ling J, Zhang WZ, Li G, Qiu W, Zheng JH, Zhao XH. Effect of bisacodyl on rats with slow transit constipation. Braz J Med Biol Res. 2018;51:e7372. [PMID: 29846410 DOI: 10.1590/1414-431x20187372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sun JW, Gu JN, Du P, Chen W. Comparison of two types of colectomy in treating slow transit constipation with or without melanosis coli. World J Gastroenterol 2015; 21(33): 9736-9740 [PMID: 26361420 DOI: 10.3748/wjg.v21.i33.9736] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
25 Mearin F, Ciriza C, Mínguez M, Rey E, Mascort JJ, Peña E, Cañones P, Júdez J; en nombre de la SEPD, la semFYC, la SEMERGEN y la SEMG. [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)]. Aten Primaria 2017;49:177-94. [PMID: 28238460 DOI: 10.1016/j.aprim.2017.01.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wang YY, Lu RY, Shi J, Zhao S, Jiang X, Gu X. CircORC2 is involved in the pathogenesis of slow transit constipation via modulating the signalling of miR-19a and neurotensin/motilin. J Cell Mol Med 2021;25:3754-64. [PMID: 33629528 DOI: 10.1111/jcmm.16211] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Dimitriou N, Shah V, Stark D, Mathew R, Miller AS, Yeung JM. Defecating Disorders: A Common Cause of Constipation in Women. Womens Health (Lond Engl) 2015;11:485-500. [DOI: 10.2217/whe.15.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 Bassotti G. New pharmacologic treatments for idiopathic chronic constipation: a financial strain for strainers. Expert Rev Gastroenterol Hepatol 2021;15:723-5. [PMID: 33798026 DOI: 10.1080/17474124.2021.1913054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]